| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/16/1999 | CA2421394A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421388A1 Novel poypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421375A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421372A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421364A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421345A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421333A1 Pro 351 polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421329A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421322A1 Pro703 polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421319A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421315A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421278A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421272A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2363540A1 A gene for transcription factor capable of altering characters of a plant and use thereof |
| 09/16/1999 | CA2327329A1 Cholesterol recognition sequence |
| 09/16/1999 | CA2324624A1 Metastatin and hyaluronate binding proteins and methods of use |
| 09/16/1999 | CA2323632A1 Hla-binding peptides and their uses |
| 09/16/1999 | CA2323460A1 Plasminogen-related gene b polypeptides |
| 09/16/1999 | CA2323236A1 Human receptor proteins; related reagents and methods |
| 09/16/1999 | CA2323109A1 Ribozymes capable of inhibiting the expression of the ccr5 receptor |
| 09/16/1999 | CA2323077A1 Method and composition for lowering low density lipoprotein cholesterol |
| 09/16/1999 | CA2323076A1 Chondrosarcoma associated genes |
| 09/16/1999 | CA2323074A1 Compositions and methods for the treatment and prevention of metastatic disorders |
| 09/16/1999 | CA2323060A1 Detection of neoplasia by analysis of saliva |
| 09/16/1999 | CA2322839A1 Peptide compositions and formulations and use of same |
| 09/16/1999 | CA2322771A1 Human membrane spanning proteins |
| 09/16/1999 | CA2322748A1 Vascular endothelial growth factor 2 |
| 09/16/1999 | CA2322741A1 Thrombin preparation and products and fibrin sealant methods employing same |
| 09/16/1999 | CA2322732A1 Secreted proteins and polynucleotides encoding them |
| 09/16/1999 | CA2322728A1 31 human secreted proteins |
| 09/16/1999 | CA2322666A1 Enhancement of the pro-fertility action of a molecule involved in sperm-egg binding |
| 09/16/1999 | CA2322663A1 Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery |
| 09/16/1999 | CA2322662A1 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 09/16/1999 | CA2322618A1 Methods of diagnosis and triage using cell activation measures |
| 09/16/1999 | CA2322508A1 Modified factor viii |
| 09/16/1999 | CA2322449A1 Biosynthetic genes for spinosyn insecticide production |
| 09/16/1999 | CA2321677A1 Novel polypeptides and nucleic acids encoding the same which are useful for treating inner ear diseases |
| 09/16/1999 | CA2321026A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | CA2244235A1 A gene for transcription factor capable of altering characters of a plant and use thereof |
| 09/15/1999 | EP0942002A1 Iron-casein complex and process for preparing the same |
| 09/15/1999 | EP0941738A1 Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria |
| 09/15/1999 | EP0941736A1 Oral immunity enhancing agent containing peptidoglycans |
| 09/15/1999 | EP0941478A1 Assay method for peptide specific t-cells |
| 09/15/1999 | EP0941369A2 Dna for evaluating the progression potential of cervical lesions |
| 09/15/1999 | EP0941365A1 Novel probes for the detection of mycobacteria |
| 09/15/1999 | EP0941355A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia |
| 09/15/1999 | EP0941354A1 Syndecan enhancer element and its use for targeting gene expression |
| 09/15/1999 | EP0941350A1 GENETICALLY MODIFIED $i(PSEUDOMONAS) STRAINS WITH ENHANCED BIOCONTROL ACTIVITY |
| 09/15/1999 | EP0941348A1 Enhanced transport with a plastid membrane transport protein |
| 09/15/1999 | EP0941347A2 Methods of producing a recombinant protein |
| 09/15/1999 | EP0941346A1 Secretory immunoglobulin a as a mucosal vaccine delivery system |
| 09/15/1999 | EP0941337A1 Synthesis and purification of hepatitis c virus-like particles |
| 09/15/1999 | EP0941336A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses |
| 09/15/1999 | EP0941335A2 Streptococcus pneumoniae polynucleotides and sequences |
| 09/15/1999 | EP0941334A2 Protease-activatable pseudomonas exotoxin a-like proproteins |
| 09/15/1999 | EP0941333A1 Immunogenic detoxified mutant e. coli lt-a toxin |
| 09/15/1999 | EP0941332A2 Carrot antifreeze polypeptides |
| 09/15/1999 | EP0941331A1 Processed polypeptides with il-16 activity, processes for their production and their use |
| 09/15/1999 | EP0941330A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 09/15/1999 | EP0941329A1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) |
| 09/15/1999 | EP0941328A1 Human breast tumor-specific proteins |
| 09/15/1999 | EP0941327A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
| 09/15/1999 | EP0941326A1 Murine guanine nucleotide exchange factor (mngef) and human homologues thereof |
| 09/15/1999 | EP0941325A1 Human homolog of the latheo gene |
| 09/15/1999 | EP0941324A1 Protein targeting to glycogen |
| 09/15/1999 | EP0941323A1 Bone morphogenetic protein-16 (bmp-16) compositions |
| 09/15/1999 | EP0941322A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation |
| 09/15/1999 | EP0941321A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
| 09/15/1999 | EP0941320A2 Human proteins having transmembrane domains and dnas encoding these proteins |
| 09/15/1999 | EP0941319A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences |
| 09/15/1999 | EP0941316A1 Human p2x purinoreceptor |
| 09/15/1999 | EP0941315A1 Immune responses using compositions containing stress proteins |
| 09/15/1999 | EP0941312A1 Proteases and their variants having peptide protease inhibitors fused to them |
| 09/15/1999 | EP0941311A2 Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates |
| 09/15/1999 | EP0941308A2 Multi-resistant bacteria, methods for obtaining them and their uses |
| 09/15/1999 | EP0941252A1 Anti-p53 single-chain antibody fragments and their uses |
| 09/15/1999 | EP0941250A1 HUMAN BLUE-LIGHT PHOTORECEPTOR hCRY2 |
| 09/15/1999 | EP0941249A1 Novel histamine h2 receptor |
| 09/15/1999 | EP0941248A1 Platelet secretory transport protein |
| 09/15/1999 | EP0941247A2 Peptide compounds useful for modulating fgf receptor activity |
| 09/15/1999 | EP0941246A2 Novel protein, its production and use |
| 09/15/1999 | EP0941245A1 Promoter for smooth muscle cell expression |
| 09/15/1999 | EP0941244A2 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a method of detecting auto-immune antibodies |
| 09/15/1999 | EP0941243A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 09/15/1999 | EP0941242A2 Secreted proteins and polynucleotides encoding them |
| 09/15/1999 | EP0941241A1 $i(BORDETELLA) STRAIN EXPRESSING THE FHA HYBRID, LIPOSOMES AND VACCINES |
| 09/15/1999 | EP0941240A1 New picornaviruses, vaccines and diagnostic kits |
| 09/15/1999 | EP0941239A1 Vertebrate homologues of unc-53 protein of c. elegans |
| 09/15/1999 | EP0941238A2 Mutant forms of fas ligand and uses thereof |
| 09/15/1999 | EP0941122A2 Compositions and methods for polynucleotide delivery |
| 09/15/1999 | EP0941120A1 Branched peptide linkers |
| 09/15/1999 | EP0941118A2 Pharmaceutical antigen-antibody preparation |
| 09/15/1999 | EP0851874B1 Novel variants of green fluorescent protein, gfp |
| 09/15/1999 | EP0832098A4 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
| 09/15/1999 | EP0776335A4 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 09/15/1999 | EP0707654B1 Bacillus thuringiensis transposon tn5401 and its use in a site-specific recombination system for bacillus thuringiensis strain development |
| 09/15/1999 | EP0586657B1 Receptor for the glucagon-like-peptide-1 (glp-1) |
| 09/15/1999 | EP0585215B1 Mutants or variants of bacillus thuringiensis producing high yields of delta endotoxin |
| 09/15/1999 | EP0567470B1 Pseudomonas peptide composition and method for producing the same |
| 09/15/1999 | CN1228814A Cassava vein mosaic virus promoters and uses thereof |